A clinical trial of an experimental vaccine against the deadly Ebola virus is set to start shortly, according to British drugmaker GlaxoSmithKline, which is co-developing the product with U.S. scientists.
Clinical trial to start soon on GSK Ebola vaccine
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.